Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nasdaq Pharmaceuticals ETF FT (FTXH)

Nasdaq Pharmaceuticals ETF FT (FTXH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family First Trust Portfolios
  • Assets Under Management 22,172,300
  • Shares Outstanding, K 850
  • 60-Month Beta 0.90
Trade FTXH with:
  • Price/Earnings ttm 23.55
  • Annual Dividend & Yield 0.23 (0.88%)
  • Most Recent Dividend 0.077 on 03/25/21
  • Management Fee 0.60%
  • Sectors:

    ETFs - Large Cap

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.20 +3.41%
on 06/03/21
26.55 -1.84%
on 06/10/21
unch (+0.02%)
since 05/17/21
3-Month
24.80 +5.08%
on 03/25/21
26.55 -1.84%
on 06/10/21
-0.16 (-0.60%)
since 03/17/21
52-Week
22.34 +16.65%
on 06/24/20
27.16 -4.05%
on 02/09/21
+3.58 (+15.90%)
since 06/17/20

Most Recent Stories

More News
Pharma ETFs in Focus Post Q1 Earnings

The slew of Q1 results have led to mixed trading in pharma ETFs over the past month.

PPH : 73.65 (-0.24%)
PJP : 81.14 (+0.14%)
IHE : 187.20 (+0.21%)
XPH : 52.45 (-0.38%)
FTXH : 26.06 (-0.30%)
Will J&J ETFs Suffer on Latest COVID-19 Vaccine Updates?

Let's take a look at some ETFs that can see adverse impacts as Johnson & Johnson's coronavirus vaccine sees a setback amid the worsening pandemic conditions.

JNJ : 165.22 (+0.48%)
XLV : 125.17 (+0.76%)
IYH : 269.89 (+0.88%)
IHE : 187.20 (+0.21%)
FTXH : 26.06 (-0.30%)
IEIH : 34.46 (+0.49%)
ETFs to Shine on Pfizer's Impressive COVID-19 Vaccine Update

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development as the outbreak worsens.

PFE : 39.48 (+0.46%)
MRNA : 202.47 (+2.34%)
IHE : 187.20 (+0.21%)
FDL : 33.64 (-1.32%)
FTXH : 26.06 (-0.30%)
IEIH : 34.46 (+0.49%)
BNTX : 214.20 (+5.08%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 102 exchange-traded funds (each a "Fund," collectively, the "Funds") advised by FTA.

FPE : 20.57 (+0.15%)
FCAL : 55.05 (-0.27%)
FEMB : 35.01 (-0.85%)
FMB : 57.40 (-0.07%)
FMHI : 56.32 (+0.04%)
RFAP : 59.34 (+0.23%)
RFDI : 71.17 (-0.79%)
RFEM : 74.65 (+0.19%)
RFEU : 76.78 (-0.47%)
FCVT : 50.62 (-0.06%)
FDIV : 50.57 (-1.07%)
FTSL : 48.13 (-0.10%)
HYLS : 48.62 (-0.08%)
LMBS : 51.05 (+0.14%)
FTHI : 21.82 (-2.06%)
FTLB : 21.54 (-1.51%)
FIXD : 53.56 (+0.36%)
LDSF : 20.29 (-0.10%)
FAB : 70.99 (-2.22%)
FEX : 84.45 (-0.90%)
FNK : 44.30 (-2.40%)
FNX : 98.17 (-1.56%)
FTA : 65.67 (-1.74%)
FYT : 51.36 (-2.31%)
FYX : 93.07 (-1.93%)
FBZ : 14.82 (-0.10%)
FCA : 30.75 (-2.81%)
FDT : 63.83 (-1.07%)
FDTS : 48.37 (+0.02%)
FEM : 27.87 (-0.28%)
FEMS : 46.73 (+0.31%)
FEP : 43.90 (-1.57%)
FJP : 52.41 (-0.63%)
FKU : 44.78 (-0.54%)
FLN : 20.82 (+0.11%)
FPA : 36.83 (-0.53%)
NFTY : 44.98 (-0.71%)
DWPP : 31.72 (+1.33%)
FTCS : 74.52 (-0.16%)
QABA : 56.59 (-3.83%)
QQEW : 109.19 (+1.02%)
QQXT : 84.84 (+0.82%)
QTEC : 152.71 (+1.30%)
TUSA : 47.28 (-1.63%)
FTRI : 14.47 (-2.95%)
GRID : 90.56 (-1.03%)
SKYY : 104.26 (+1.39%)
AIRR : 40.44 (-2.69%)
DDIV : 31.04 (-3.34%)
DVLU : 23.23 (-4.01%)
DVOL : 26.56 (-0.42%)
FICS : 34.54 (-0.56%)
FID : 18.72 (-1.47%)
FTXD : 33.07 (+0.12%)
FTXG : 25.58 (-1.12%)
FTXH : 26.06 (-0.30%)
FTXL : 66.02 (+0.75%)
FTXN : 17.75 (-4.67%)
FTXO : 30.56 (-4.77%)
LEGR : 42.51 (unch)
MDIV : 17.04 (-1.16%)
RDVY : 47.04 (-1.55%)
RNDM : 57.36 (+0.20%)
RNDV : 29.33 (-1.69%)
RNLC : 31.59 (-1.12%)
RNMC : 28.65 (-2.86%)
SDVY : 28.74 (-2.27%)
TDIV : 56.79 (-0.23%)
J&J ETFs to Shine Bright as FDA Grants EUA for Coronavirus Vaccine

Johnson & Johnson's receipt of EUA for its single-shot COVID-19 vaccine will strengthen the U.S. government's position in the fight against the pandemic and benefit ETFs with high exposure to the pharmaceutical...

JNJ : 165.22 (+0.48%)
XLV : 125.17 (+0.76%)
IYH : 269.89 (+0.88%)
IHE : 187.20 (+0.21%)
FTXH : 26.06 (-0.30%)
IEIH : 34.46 (+0.49%)
Pharma ETFs in Focus Post Q4 Earnings

Healthcare Q4 results seem robust given that it is the fourth-best sector from a revenue growth look and the sixth-strongest in terms of earnings growth.

JNJ : 165.22 (+0.48%)
PFE : 39.48 (+0.46%)
MRK : 77.23 (+0.81%)
LLY : 222.21 (+0.66%)
BMY : 66.77 (-0.22%)
PPH : 73.65 (-0.24%)
PJP : 81.14 (+0.14%)
IHE : 187.20 (+0.21%)
XPH : 52.45 (-0.38%)
FTXH : 26.06 (-0.30%)
ETFs to Shine as Pfizer's COVID-19 Vaccine Gets a Nod in Europe

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.

DHS : 78.79 (-1.08%)
FDL : 33.64 (-1.32%)
HDV : 96.64 (-1.03%)
FTXH : 26.06 (-0.30%)
IEIH : 34.46 (+0.49%)
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds

First Trust Advisors L.P. ("FTA") announces the declaration of distributions for 127 exchange-traded funds (each a "Fund," collectively, the "Funds") advised by FTA.

FPE : 20.57 (+0.15%)
FLM : 55.25 (-1.77%)
FCAL : 55.05 (-0.27%)
FEMB : 35.01 (-0.85%)
FMB : 57.40 (-0.07%)
FMHI : 56.32 (+0.04%)
RFAP : 59.34 (+0.23%)
RFDI : 71.17 (-0.79%)
RFEM : 74.65 (+0.19%)
RFEU : 76.78 (-0.47%)
FCVT : 50.62 (-0.06%)
FDIV : 50.57 (-1.07%)
FTSL : 48.13 (-0.10%)
FTSM : 59.96 (unch)
HYLS : 48.62 (-0.08%)
LMBS : 51.05 (+0.14%)
FTHI : 21.82 (-2.06%)
FTLB : 21.54 (-1.51%)
FAAR : 29.50 (-2.99%)
FIXD : 53.56 (+0.36%)
LDSF : 20.29 (-0.10%)
FAB : 70.99 (-2.22%)
FAD : 115.61 (+0.31%)
FEX : 84.45 (-0.90%)
FNK : 44.30 (-2.40%)
FNX : 98.17 (-1.56%)
FNY : 72.65 (+0.32%)
FTA : 65.67 (-1.74%)
FYC : 72.03 (-1.00%)
FYT : 51.36 (-2.31%)
FYX : 93.07 (-1.93%)
FCA : 30.75 (-2.81%)
FDT : 63.83 (-1.07%)
FDTS : 48.37 (+0.02%)
FEMS : 46.73 (+0.31%)
FEP : 43.90 (-1.57%)
FEUZ : 47.99 (-2.27%)
FGM : 58.40 (-0.99%)
FJP : 52.41 (-0.63%)
FKU : 44.78 (-0.54%)
FPA : 36.83 (-0.53%)
FSZ : 68.20 (-1.85%)
NFTY : 44.98 (-0.71%)
DWPP : 31.72 (+1.33%)
FTCS : 74.52 (-0.16%)
QABA : 56.59 (-3.83%)
QCLN : 65.10 (+2.07%)
QQEW : 109.19 (+1.02%)
QQXT : 84.84 (+0.82%)
QTEC : 152.71 (+1.30%)
TUSA : 47.28 (-1.63%)
BICK : 40.24 (+0.30%)
CARZ : 61.20 (-0.11%)
CIBR : 46.78 (+1.37%)
FDNI : 45.87 (+1.75%)
FPXE : 29.87 (-0.55%)
FPXI : 67.24 (+0.34%)
FTAG : 29.84 (-1.88%)
FTRI : 14.47 (-2.95%)
GRID : 90.56 (-1.03%)
NXTG : 76.31 (+0.07%)
SKYY : 104.26 (+1.39%)
AIRR : 40.44 (-2.69%)
DALI : 24.76 (-0.36%)
DDIV : 31.04 (-3.34%)
DVLU : 23.23 (-4.01%)
DVOL : 26.56 (-0.42%)
FID : 18.72 (-1.47%)
FTXD : 33.07 (+0.12%)
FTXG : 25.58 (-1.12%)
FTXH : 26.06 (-0.30%)
FTXL : 66.02 (+0.75%)
FTXN : 17.75 (-4.67%)
FTXO : 30.56 (-4.77%)
FTXR : 33.69 (-1.65%)
IFV : 24.59 (-0.85%)
LEGR : 42.51 (unch)
MDIV : 17.04 (-1.16%)
RDVY : 47.04 (-1.55%)
RNDM : 57.36 (+0.20%)
RNDV : 29.33 (-1.69%)
RNEM : 51.14 (-0.63%)
RNLC : 31.59 (-1.12%)
RNMC : 28.65 (-2.86%)
RNSC : 29.44 (-1.98%)
ROBT : 54.01 (+0.33%)
SDVY : 28.74 (-2.27%)
TDIV : 56.79 (-0.23%)
Pfizer's Coronavirus Vaccine Gets a Nod in UK: ETFs to Shine

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in coronavirus vaccine development.

PFE : 39.48 (+0.46%)
DHS : 78.79 (-1.08%)
FDL : 33.64 (-1.32%)
HDV : 96.64 (-1.03%)
FTXH : 26.06 (-0.30%)
IEIH : 34.46 (+0.49%)
What Lies Ahead for Pfizer ETFs After Another Round of Upbeat Vaccine Data

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging progress in the coronavirus vaccine development.

DHS : 78.79 (-1.08%)
FDL : 33.64 (-1.32%)
HDV : 96.64 (-1.03%)
FTXH : 26.06 (-0.30%)
IEIH : 34.46 (+0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The First Trust Nasdaq Pharmaceuticals ETF is an exchange-traded fund. The investment objective of the Fund is to seek investment results that correspond generally to the price and yield, before the Fund's fees and expenses, of an index called the Nasdaq US Smart Pharmaceuticals Index. The Fund seeks...

See More

Key Turning Points

3rd Resistance Point 26.41
2nd Resistance Point 26.35
1st Resistance Point 26.25
Last Price 26.06
1st Support Level 26.08
2nd Support Level 26.03
3rd Support Level 25.92

See More

52-Week High 27.16
Last Price 26.06
Fibonacci 61.8% 25.32
Fibonacci 50% 24.75
Fibonacci 38.2% 24.18
52-Week Low 22.34

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar